Therapeutic Use of Intravenous Eptifibatide in Patients Undergoing Percutaneous Coronary Intervention: Acute Coronary Syndromes and Elective Stenting

By Juan F. Granada   Neal S. Kleiman  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 1, 2004-01 ,pp. : 31-41

Adis International

Access to resources Recommend Favorite

Eptifibatide reduces the incidence of death or myocardial infarction in patients undergoing non-urgent coronary stenting

By  

Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Effects of Remifentanil and Fentanyl on the Cell-mediated Immune Response in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery

By von Dossow V   Luetz A   Haas A   Sawitzki B   Wernecke KD   Volk HD   Spies CD  

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1235-1247

Field House Publishing

Access to resources Recommend Favorite

Atorvastatin has rapid and early anti-inflammatory effects in patients with acute coronary syndrome

By  

Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Mechanisms mediating the vasodilatory effects of N-hydroxy-l-arginine in coronary arteries

By Abdul-Hussain M.N.   Yan L.J.   Hussain S.N.A.  

European Journal of Pharmacology, Vol. 305, Iss. 1, 1996-06 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite